Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea’s Leading Bone Densitometry Platform
Medimaps Group Announces Partnership With OSTEOSYS CO., LTD to Bring Trabecular Bone Score to Korea’s…
Webinar – Advances in osteoporosis screening: Finding more patients at risk
We sponsored an AuntMinnie's webinar on advances in osteoporosis screening and finding more patients at…
Book a meeting with Medimaps Group at the 2022 Santa Fe Bone Symposium
Join Medimaps Group (booth #101) at the 2022 Santa Fe Bone Symposium to talk…
Presentation of 2022 ISCD Award-Winning Abstract on TBS and Denosumab
At the 2022 ISCD Annual Meeting, our CEO Prof. Didier Hans presented his award-winning abstract…
Panel Discussion on Integrating TBS into Clinical Practice with Dr. Lewiecki and Dr. Singer
Alongside Medimaps Group, Dr. Lewiecki and Dr. Singer, two world-renowned leaders in the field of…
[PRESS RELEASE]Medical Reimbursement Now Available for Trabecular Bone Score (TBS), an Advanced Medtech Solution with Artificial Intelligence Capabilities, for Osteoporsis Fracture Risk Assessment
GENEVA--MEDIMAPS GROUP (www.medimapsgroup.com), a Swiss/Global med-tech company specializing in image processing software for the assessment…
[BOOK A MEETING] Join us at the Nevada Clinical Endocrinologists’ Association
Join us at the Nevada Clinical Endocrinologists’ Association in Reno, Nevada on April 2nd, 2022…
Join Medimaps Group for a Panel Discussion on Integrating TBS into Clinical Practice
Join Medimaps Group during the 2022 ISCD Annual Meeting on Thursday March 31st 1.20pm -…